- Here are the companies seeing the most trading activity on the Toronto Stock Exchange
- CubicFarm Systems Corp. (TSX:CUB) shares rose 50 per cent by midday and opened trading at $0.02 per share
- Oncolytics Biotech Inc. (TSX:ONC) opened trading at C$2.16 per share and rose more than 15 per cent by midday
- Constellation Software Inc. (TSX:CSU) opened trading at C$2,710.63 per share and added C$41.23 to its share price
Here are some of the companies seeing the most trading activity on the Toronto Stock Exchange, be it by per cent or dollar gains.
CubicFarm Systems Corp. (TSX:CUB) announced Monday that its automated, controlled-environment growing technology is now fully commissioned at Vertical Acres Farm, an Indiana-based produce company.
CubicFarm Systems Corp is an ag-tech company providing automated growing systems for fresh produce and animal feed. It offers turnkey, commercial scale, hydroponic, automated controlled-environment growing systems that can grow predictably and sustainably for 12 months of the year virtually anywhere on Earth. The company enables its customers to grow locally and to provide their markets with safe, sustainable, secure, and fresh ingredients that are consistent in colour, size, taste and nutrition and allows for a longer shelf life.
Speaking on this news, CubicFarms’ CEO, John de Jonge, stated that bringing this project to fruition for Vertical Acres, provides that team the means to cultivate high-quality, locally grown produce in Indiana and the surrounding regions.
“[Vertical Acres Farm] will enable freshly picked, locally grown lettuce and nutrient packed microgreens to his surrounding areas even when snow is falling in January. Our patented technology empowers them to maximize production efficiency per cubic foot while significantly reducing the physical footprint compared to traditional farming operations.”
CubicFarm Systems Corp. (CUB) shares rose 50 per cent by midday and have grown 100 per cent in the past month. CUB opened trading at $0.02 per share.
Oncolytics Biotech Inc. (TSX:ONC) released updated results from its BRACELET-1, a randomized phase 2 trial in HR+/HER2- metastatic breast cancer.
This development-stage biopharmaceutical company is focused on the discovery and development of pharmaceutical products for the treatment of cancers that have not been treated with therapeutics.
The BRACELET-1 (BReast cAnCEr with the Oncolytic Reovirus PeLareorEp in CombinaTion with anti-PD-L1 and Paclitaxel) is an open-label, phase 2, randomized study in patients with HR+/HER2-, endocrine-refractory metastatic breast cancer being conducted under a co-development agreement with Pfizer Inc. (NYSE:PFE) and Merck KGaA, Darmstadt, Germany.
Its test results released Monday reported that the pelareorep-paclitaxel combination reduced risk of disease progression by 71 per cent compared to paclitaxel monotherapy.
Oncolytics Biotech Inc. (ONC) opened trading at C$2.16 per share and rose more than 15 per cent by midday and more than 9 per cent in the past month.
One of the top dollar gainers on the TSX was Constellation Software Inc. (TSX:CSU), which added C$41.23 to its share price Monday.
Constellation Software Inc. (CSU) opened trading at C$2,710.63 per share and has grown 4.3 per cent in the last month.
The Toronto-based software developer recently completed its purchase of Winklevoss Technologies, a provider of defined benefit pension plan valuation and administration software. The purchase was made through its operating group Perseus, which acquires and invests in software businesses. Click here to read more on that news.
The material provided in this article is for information only and should not be treated as investment advice. For full disclaimer information, please click here.
